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Damage to the central nervous system (CNS) from degenerative diseases or traumatic 
injuries is particularly devastating due the limited regenerative capabilities of the CNS. 
Among the current approaches, stem cell-based regenerative medicine has shown great 
promise in achieving significant functional recovery by taking advantage of the self-renewal 
and differentiation capabilities of stem cells, which include pluripotent stem cells (PSCs), 
mesenchymal stem cells (MSCs) and neural stem cells (NSCs).[1] However, the low survival 
rate upon transplantation has been a longstanding barrier for scientists and clinicians to 
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overcome.[2] To this end, numerous types of natural and synthetic biomaterial scaffolds have 
been developed, the two main classes being hydrogels and nanofibers, in an attempt to 
mimic the cellular microenvironment, support cellular growth and improve cellular 
viability.[3] Yet, designing scaffolds with defined properties to selectively guide stem cell 
differentiation towards a specific neural cell lineage is still an ongoing challenge.
For CNS regeneration, the selective differentiation of NSCs into either neurons or 
oligodendrocytes (as opposed to astrocytes) is highly desirable.[4] A number of approaches 
have been employed to guide differentiation into neurons, including genetic modifications, 
growth factors, cytokines, substrate topography and even nanomaterials.[5] However, 
oligodendrocyte differentiation has proven to be much more elusive, resulting in only a 
small percentage of the differentiated cell population.[6] The primary approach to guide 
oligodendrocyte differentiation has focused on either developing culture media containing a 
combination of growth factors or the forced expression of key oligodendrocyte-promoting 
transcription factors via viral gene transfection.[7] However, developing a biomaterials-
approach to achieve efficient differentiation of NSCs into mature oligodendrocytes, which 
are the myelinating cells of the CNS, while eliminating the potential adverse or variable 
side-effects from growth factors and viral gene vectors, would be highly beneficial.[8]
Herein, we report the use of a graphene-based nanomaterial for designing hybrid 
nanofibrous scaffolds to guide NSC differentiation into oligodendrocytes (Figure 1). 
Graphene-based nanomaterials, such as graphene oxide (GO), have recently gained 
considerable interest for tissue engineering applications due to their favorable chemical, 
electrical and mechanical properties.[9] Besides serving as a highly elastic and flexible 
structural reinforcement, substrates coated with GO have been demonstrated to promote the 
growth and differentiation of various stem cell lines including induced PSCs, MSCs and 
NSCs.[10] Based on these considerations, we demonstrate the use of GO as an effective 
coating material in combination with electrospun nanofibers for the selective differentiation 
of NSCs into oligodendrocytes. By varying the amount of GO coating on the nanofibers, we 
observed a GO concentration-dependent change in the expression of key neural markers, 
wherein coating with a higher concentration of GO was seen to promote differentiation into 
mature oligodendrocytes. Further investigation into the role of GO-coating on the 
nanofibrous scaffolds showed the overexpression of a number of key integrin-related 
intracellular signaling molecules that are known to promote oligodendrocyte differentiation 
in normal development.
Electrospun nanofiber scaffolds exhibit several key properties that are advantageous for 
neural tissue engineering including a high degree of porosity, high surface-to-volume ratio, 
and a relatively close structural mimic of the native extracellular matrix (ECM).[11] From 
the wide array of polymeric materials available, we used polycaprolactone (PCL) to generate 
our nanofibrous scaffolds. PCL is a biodegradable and biocompatible polyester approved by 
the FDA for use in the human body as a drug delivery device and suture, and is also widely 
used for neural tissue engineering.[12] In our studies, PCL was electrospun onto a metallic 
collector and then transferred to glass substrates for cell culture using a medical grade 
adhesive. Nanofibers with an average diameter of 200–300 nm were generated, which is a 
fiber size range that has been reported to be favorable for oligodendrocyte culture, 
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potentially due to the close morphological resemblance to axons[13] (Figure 2a). Thin-
layered graphene oxide (GO) was then synthesized and dispersed in deionized water (Figure 
S1). The hydrophobic PCL nanofibers were exposed to oxygen plasma to render the surface 
hydrophilic (Figure S2). The GO was then deposited on the PCL nanofiber surface, thus 
allowing for the efficient and uniform coating of the PCL nanofiber surface with GO, as 
seen with field emission scanning electron microscopy (FE-SEM; Figure 2b and Figure S3) 
and helium ion microscopy (Figure S4).
For the culture of NSCs, the scaffolds were then coated with laminin, a well-established 
ECM protein which is essential for the adhesion, growth and differentiation of NSCs.[14] 
Green fluorescent protein-labeled rat NSCs were then seeded onto the scaffolds and the 
morphology was monitored using fluorescence microscopy. After six days of culture, a 
significant difference in the cellular morphology was evident on GO-coated nanofibers 
compared to the nanofibers alone (Figure S5). FE-SEM shows cell attachment on these 
surfaces in greater detail, wherein the cells on the GO-coated nanofibers display extensive 
branching of cell processes (Figure 2c–d and Figure S6). This type of extensive process 
extension is a characteristic attribute reported to distinguish oligodendrocytes from other 
neural cells.[15] This difference in cellular morphology provides evidence for the potential 
ability of our hybrid scaffolds to enhance NSC differentiation into oligodendrocytes.
To systematically investigate the effect of GO-coating on NSC differentiation, we generated 
hybrid scaffolds with varying amounts of GO-coating. Solutions containing three different 
concentrations of GO (0.1, 0.5 and 1.0 mg/mL) were deposited on oxygen plasma-treated 
PCL nanofibers. The degree of coating using the various GO concentrations was then 
observed using FE-SEM (Figure 3a). GO-coating of PCL with 0.1 mg/mL, indicated as 
PCL-GO (0.1), shows the clear presence of GO compared to PCL nanofibers alone, with 
uniform coating on the surface of individual fibers. In contrast, PCL-GO (0.5) and PCL-GO 
(1.0) exhibit a much greater extent of GO attachment on the nanofibrous surface, wherein 
PCL-GO (1.0) shows the highest degree of GO coating and connectivity between fibers. 
This was confirmed quantitatively using Raman Spectroscopy, where the characteristic 
peaks of the D band (~1350 cm−1) and G band (~1600 cm−1) indicate the presence of GO. 
Comparison of the Raman intensity of these peaks further supports the trend described 
above in terms of concentration-dependent GO coating on the PCL nanofiber surfaces 
(Figure 3b). Moreover, the nanofibrous scaffolds at all three concentrations show 
significantly higher GO content compared to control glass surfaces coated with the same 
respective amounts of GO (Figure 3b). The higher surface area-to-volume of the nanofibers 
available for GO attachment, in conjunction with the 3D structure of these scaffolds, may 
attribute to this difference in coating.
These various PCL-GO substrates were then used to examine the influence of GO-coating 
on modulating NSC differentiation. For comparison, the following control substrates were 
used: 1) PLL-coated glass (standard substrate for in vitro neural cultures), 2) PCL nanofibers 
alone, and 3) GO-coated glass (at the abovementioned three GO concentrations). All of the 
substrates were coated with laminin to facilitate NSC attachment, and the cells were 
harvested after six days of culture to compare the gene expression of key neural markers. 
Quantitative PCR (qPCR) was utilized to compare gene expression of three key markers that 
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are indicative of differentiated NSCs: glial fibrillary acidic protein (GFAP; astrocytes), beta-
III tubulin (TuJ1; neurons) and myelin basic protein (MBP; mature oligodendrocytes). First, 
it is important to note that both the PCL nanofibers alone and GO-coated glass (at all three 
concentrations) individually show enhanced oligodendrocyte gene expression, with about a 
2-fold increase in MBP expression (Figure 3c). At the same time, TuJ1 shows only about a 
1.3-fold increase and GFAP shows about a 0.5-fold decrease in expression, which indicates 
a stronger preference for differentiation towards oligodendrocytes rather than neurons and 
astrocytes (Figure 3c). While no reports exist for the effect of graphene-based nanomaterials 
on oligodendrocyte differentiation, previous studies have reported that electrospun 
nanofibers can act as permissive culture platforms for oligodendrocyte culture.[16]
Since each individual component (nanofibers and GO) displayed a favorable trend in NSC 
differentiation towards oligodendrocytes, we hypothesized that the combination of GO and 
nanofibers in a single scaffold may have a synergistic effect. In the PCL-GO samples, we 
observed a remarkable trend in gene expression of these neural markers. The nanofibers 
coated at the lowest GO concentration (0.1 mg/mL) showed a 6.5-fold increase in MBP, 
which is much higher than the expression on PCL nanofibers alone and GO-coated glass 
controls (Figure 3c). Interestingly, this enhancement in MBP expression was even more 
pronounced when the concentration of GO was further increased, wherein the cells on PCL-
GO (0.5) showed an 8.9-fold increase and PCL-GO (1.0) showed a 9.9-fold increase in MBP 
expression (Figure 3c). Based on the data, there is no statistically significant difference in 
MBP expression on the PCL-GO (0.5) and PCL-GO (1.0), indicating the saturation of GO 
on the PCL nanofiber surface. The overall increase in MBP expression of the cells grown on 
the PCL-GO substrates points to the role of GO in the observed result, in which the 3D PCL 
nanotopography serves to increase the amount of GO coating and the consequent surface 
interface in contact with the NSCs compared to the traditional 2D surfaces. In addition, the 
simultaneous decrease in GFAP expression and relatively small increase in TuJ1 expression 
provides further evidence that the hybrid scaffold promotes selective NSC differentiation, 
with a strong preference towards oligodendrocyte lineage cells (Figure 3c). To explore the 
potential of these hybrid scaffolds as a culture platform for oligodendrocyte differentiation, 
we elected to use PCL-GO (1.0) for all subsequent experiments (termed PCL-GO hereafter). 
In regard to biocompatibility, NSCs grown on these scaffolds show excellent survival, as 
found with cell viability assays (Figure S7).
We next sought to further characterize the degree of differentiation into oligodendrocytes by 
examining the expression of well-established oligodendrocyte markers at the genetic- and 
cellular-level. After six days of culture, the cells grown on PCL-GO were immunostained 
for the early marker Olig2 and the mature marker MBP (Figure 4a–b). The immunostained 
cells show extensive expression of both the nuclear-localized Olig2 and the cytosolic MBP. 
A similar expression was also observed for the oligodendrocyte-specific surface markers O4 
(early) and GalC (mature) (Figure S8). Expression of these early and mature protein markers 
confirms the successful NSC differentiation into oligodendrocytes. The degree of 
differentiation was further quantified by determining the percentage of cells expressing 
Olig2 and MBP on the various substrates (Figure 4c–d). While the conventional PLL-coated 
glass substrates showed only about 9% of the cells expressing Olig2, both the PCL only and 
GO-coated glass substrates showed about 16% Olig2-expressing cells (Figure 4c). On the 
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other hand, the PCL-GO substrate displayed about 33% of the cells expressing Olig2, which 
is significantly higher than all other conditions (Figure 4c). A similar trend was also 
observed for MBP expression, wherein 26% of the cells on PCL-GO were positive for MBP, 
which corroborates the gene expression results shown earlier (Figure 3c). Comparison of the 
percentage of cells stained for TuJ1 (neurons) and GFAP (astrocytes) further supports the 
selective differentiation into oligodendrocytes, with PCL-GO displaying a significant 
decrease in GFAP-positive cells and a minor increase in the number of TuJ1-positive cells 
(Figure S9). Given the difficulty in achieving the spontaneous differentiation of stem cells 
into oligodendrocytes, our unique graphene-nanofiber hybrid scaffolds exhibit a significant 
enhancement in oligodendrocyte formation.
To further confirm that the hybrid scaffolds promote oligodendrocyte differentiation, we 
evaluated changes in gene expression for a variety of well-known early and mature 
oligodendrocyte-specific markers. qPCR was carried out for detecting the gene expression 
of: 1) early markers including 2’,3’-cyclic-nucleotide 3’-phosphodiesterase (CNP), platelet-
derived growth factor receptor alpha (PDGFRα), Olig1 and Olig2, and 2) mature markers 
including proteolipid protein (PLP), MBP, myelin-associated glycoprotein (MAG), myelin 
oligodendrocyte glycoprotein (MOG), adenomatous polyposis coli (APC), glutathione S-
transferase-pi (GST-π) and galactocerebroside (GalC). For all genes of interest, NSCs on 
PCL-GO exhibited the strongest level of expression compared with all other control 
substrates (Figure 4e–f and Figure S10). Interestingly, several of the known genes indicative 
of myelinating oligodendrocytes also showed a substantial increase in gene expression. For 
instance, MAG and MOG, which are glycoproteins reported to be crucial during the 
myelination process in the CNS,[15] were seen to have a 17-fold and 19-fold increase in gene 
expression, respectively (Figure 4f). Taken together, these results confirm that NSCs 
cultured on PCL-GO substrates exhibit a strong preference towards oligodendrocyte 
differentiation.
These hybrid scaffolds provide a unique microenvironment that was found to be permissive 
to oligodendrocyte formation. Yet, how the extracellular cues from these hybrid scaffolds 
modulate intracellular signaling pathways to control this selective differentiation remains to 
be explored. Numerous studies report the importance of stem cell-extracellular matrix 
interactions in directing oligodendrocyte differentiation.[17] These interactions have been 
observed to modulate intracellular signaling pathways, primarily through the activation of 
integrin receptors found on the cellular membrane. Integrin-mediated signaling has been 
found to be especially important for facilitating fundamental oligodendrocyte processes 
including survival, differentiation and myelination.[18] Culminating evidence from previous 
reports suggests the role of several key signaling proteins downstream of integrins in 
regulating oligodendrocyte differentiation and development, including focal adhesion kinase 
(FAK), Akt, integrin-linked kinase (ILK) and Fyn kinase (Fyn)[18] (Figure 5a). Therefore, 
we investigated whether oligodendrocyte differentiation-related signal transduction is 
promoted in NSCs cultured on PCL-GO.
Among the various cell signaling proteins, we examined the expression of FAK, Akt, ILK 
and Fyn, which have been found to mediate cytoskeletal remodeling and process extension 
during oligodendrocyte development. Moreover, disruption of each of these proteins has 
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been reported to cause a variety of developmental defects including reduced process 
extension, aberrant myelin formation and attenuated expression of myelin proteins.[19] We 
found that NSCs cultured on the GO-coated surfaces enhanced the gene expression of all of 
these factors (Figure 5b). These signaling molecules exhibited the same trend in expression, 
wherein the GO-coated glass showed higher expression than PCL, and PCL-GO showed the 
strongest level of expression with a 2.6-fold increase in FAK and about a 1.7-fold increase 
in Akt, ILK and Fyn (Figure 5b). Additionally, treating the cells grown on PCL-GO 
scaffolds with cell signaling inhibitors showed a significant decrease in gene expression of 
mature oligodendrocyte markers, which provides further evidence for the potential role of 
such cellular signaling in the observed oligodendrocyte differentiation (Figure S11). 
Collectively, this data supports the role of GO-coating in the upregulation of these 
downstream molecules in the integrin signaling pathway and may explain, at least in part, 
the enhanced oligodendrocyte differentiation of NSCs on our hybrid scaffolds.
In order to further elucidate this correlation, we sought to observe cellular co-localization of 
markers indicative of both integrin signaling and oligodendrocyte differentiation using 
confocal microscopy. Dual staining was carried out for: 1) Olig2, an oligodendrocyte 
marker, and 2) FAK, one of the main regulators of integrin-ECM signaling[19d] and found in 
our study to show the highest expression in cells cultured on PCL-GO. The immunostaining 
for Olig2 (purple) and FAK (orange) was compared for NSCs cultured on PCL-GO with the 
other control substrates (Figure 5c). As observed earlier, cells grown on PCL-GO showed 
the strongest intensity and highest number of cells expressing Olig2, with minimal 
expression on the glass control and moderate expression on PCL and GO. A similar trend 
was also observed in FAK staining, which corresponds to the gene expression levels shown 
in Figure 5b. Since the localization of FAK is in the cytoplasm and Olig2 is in the nucleus, 
the co-localization of the two markers within the same cell can be easily visualized. 
Interestingly, the cells expressing FAK also expressed Olig2, a phenomenon that was 
observed on all substrates (Figure 5c). Moreover, PCL-GO showed the strongest expression 
of both markers and the highest number of cells co-expressing FAK and Olig2. Together, 
our data suggests that the GO-coating on the nanofiber scaffolds may promote 
oligodendrocyte differentiation through specific microenvironmental interactions which 
activate integrin-related intracellular signaling.
Overall, we have demonstrated the capability of a unique graphene-nanofiber hybrid 
scaffold to provide instructive physical cues that lead to the selective differentiation of 
neural stem cells into mature oligodendrocytes, without introducing differentiation inducers 
in the culture media. The ability to selectively guide stem cell differentiation by merely 
changing the properties of an underlying biomaterial scaffold is a valuable approach for 
tissue engineering, which can help complement or potentially eliminate the use of 
exogenous differentiation inducers such as viral gene vectors, growth factors and small 
molecule drugs. Moreover, our hybrid scaffold is exceptional in that it combines the well-
established properties of nanofibers and graphene-based nanomaterials. For instance, 
nanofibers have been shown to provide ideal topography for fabricating nerve guidance 
conduits, directing neurite outgrowth and promoting axonal regeneration.[3a, 11] On the other 
hand, graphene-based nanomaterials provide permissive surfaces for protein and cell 
adhesion, as well as high conductivity to mediate electrical stimulation for supporting 
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neuronal electrophysiology.[20] In turn, a hybrid scaffold which combines the morphological 
features of nanofibers and the unique surface properties of graphene in a single culture 
platform can be highly beneficial. We envision that such a platform can serve as a powerful 
tool for developing future therapies for CNS-related diseases and injuries.
Supplementary Material
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Schematic diagram depicting the fabrication and application of graphene-nanofiber hybrid 
scaffolds. Polymeric nanofibers (comprised of polycaprolactone) generated using 
electrospinning were subsequently coated with graphene oxide (GO) and seeded with neural 
stem cells (NSCs). NSCs cultured on the graphene-nanofiber hybrid scaffolds show 
enhanced differentiation into oligodendrocyte lineage cells.
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Morphology of nanofibrous scaffolds and cultured NSCs on the scaffolds. (a,b) Field 
emission scanning electron microscopy (FE-SEM) images of PCL nanofibers (a) and PCL 
nanofibers coated with GO using 1.0 mg/mL GO solution (b). Scale bars: 2 µm. (c,d) FE-
SEM of differentiated NSCs cultured on PCL nanofiber scaffolds (c) and graphene-
nanofiber hybrid scaffolds (d) after six days of culture. Cells are pseudo-colored blue for 
contrast. The differentiated cells on the graphene-nanofiber hybrid scaffolds (d) show a clear 
morphological difference in terms of process extension compared to nanofiber scaffolds 
alone (c). Scale bars: 10 µm.
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Effect of concentration-dependent GO-coating on NSC differentiation. (a) FE-SEM images 
of PCL nanofibers coated with GO solutions of varying concentrations: 0.0 mg/mL [PCL], 
0.1 mg/mL [PCL-GO (0.1)], 0.5 mg/mL [PCL-GO (0.5)] and 1.0 mg/mL [PCL-GO (1.0)]. 
Scale bars: 1 µm. (b) Raman spectroscopy of glass and PCL nanofibers coated with varying 
concentrations of GO. (c) Quantitative PCR (qPCR) of NSCs grown on various substrates 
from RNA isolated after six days of culture. The plot shows fold change in gene expression 
of markers indicative of neurons (TuJ1), astrocytes (GFAP) and oligodendrocytes (MBP), 
wherein the PCL-GO substrates show the highest expression of MBP. The gene expression 
is relative to GAPDH, and normalized to the conventional PLL-coated glass control. 
Student’s unpaired t-test was used for evaluating significance (* = p < 0.05, ** = p < 0.01, 
n.s. = no significance), compared to the control glass substrates (denoted above the bar) or 
between different substrates.
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Enhancement in oligodendrocyte differentiation on PCL-GO. (a,b) Fluorescence image of 
NSCs grown on PCL-GO after six days of culture, stained for the early oligodendrocyte 
marker Olig2 (a) and the mature oligodendrocyte marker MBP (b). Scale bars: 20 µm. (c,d) 
Quantitative comparison on various substrates of the percentage of cells expressing Olig2 
(c) and MBP (d). Graphs show mean ± s.e.m, n=3, comparison by ANOVA – * = p < 0.01. 
(e,f) Quantitative PCR analysis was used to assess the gene expression of early 
oligodendrocyte markers including CNP, PDGFR, Olig2 and Olig2 (e), and mature 
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oligodendrocyte markers including PLP, MBP, MAG and MOG (f). The gene expression is 
relative to GAPDH, and normalized to the conventional PLL-coated glass control. Student’s 
unpaired t-test was used for evaluating significance (* = p < 0.05, ** = p < 0.01), compared 
to the control glass substrate.
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Expression of integrin-related signaling proteins on nanofibrous scaffolds. (a) Schematic 
diagram depicting the integrin signaling proteins involved in oligodendrocyte differentiation 
and development. (b) Quantitative PCR analysis was used to assess the gene expression of 
the integrin signaling proteins FAK, Akt, ILK and Fyn. The gene expression is relative to 
GAPDH, and normalized to the conventional PLL-coated glass control. Student’s unpaired 
t-test was used for evaluating significance (* = p < 0.05, ** = p < 0.01), compared to the 
control glass substrate. (c) Confocal image of NSCs grown on various substrates (PLL-
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coated glass, PCL only, GO-coated glass and PCL-GO) after six days of culture, co-stained 
for Olig2 (purple) and FAK (orange). Scale bar: 20 µm.
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